The effect of electroacupuncture on insulin-like growth factor-I and oxidative stress in an animal model of renal failure-induced hypertension

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 634-643

  Oh, Young Il ^a   Yang, Eun Jin ^b   Choi, Sun Mi ^b   Kang, Chang Won ^a  

^a Chonbuk National University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Acupuncture; Electroacupuncture; Heme oxygenase; Hypertension; iNOS; Insulin like growth factor I; Nitric oxide synthase; Oxidative stress

Indexed keywords

CREATININE; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITROGEN; SOMATOMEDIN C; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ALBUMINURIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD ANALYSIS; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ELECTROACUPUNCTURE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL FAILURE INDUCED HYPERTENSION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ELECTROACUPUNCTURE; HYPERTENSION, RENAL; INSULIN-LIKE GROWTH FACTOR I; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84865835267     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000339640     Document Type: Article

References (54)

1. Candela L, Yucha C: Renal regulation of extracellular fluid volume and osmolality (review). Nephrol Nurs J 2004; 31: 397-404, 444, quiz 405-406.
2. Trachtman H: Sodium and water homeostasis (review). Pediatr Clin North Am 1995; 42: 1343-1363.
3. Velez JC: The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol 2009; 5: 89-100.
4. Yucha C: Renal regulation of acid-base balance. Nephrol Nurs J 2004; 31: 201-206, quiz 207-208.
5. Narayanan R, Cardella CJ, Cattran DC, Cole EH, Tinckam KJ, Schiff J, Kim SJ: Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients. Am J Kidney Dis 2010; 56: 961-970.
6. Canellos HM, Cooper J, Paek A, Chien J: Multiple calcified deposits along the eyelid margins secondary to chronic renal failure and hyperparathyroidism. Optometry 2005; 76: 181-184.
7. Hausberg M, Mann J, Kuhn K: The kidneys and hypertension (in German). Dtsch Med Wochenschr 2008; 133: 1853-1856.
8. Flachskampf FA, Gallasch J, Gefeller O, Gan J, Mao J, Pfahlberg AB, Wortmann A, Klinghammer L, Pflederer W, Daniel WG: Randomized trial of acupuncture to lower blood pressure. Circulation 2007; 115: 3121-3129.
9. Ebrahim Z, Yellon DM, Baxter GF: Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension. Exp Gerontol 2007; 42: 807-814.
10. Hellstrom HR: The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes Yincluding reducing the risk of age and atherosclerosis. Med Hypotheses 2007; 68: 415-433.
11. Xiaowu H, Xiufeng J, Xiaoping Z, Bin H, Laixing W, Yiqun C, Jinchuan L, Aiguo J, Jianmin L: Risks of intracranial hemorrhage in patients with Parkinson's disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord 2010; 16: 96-100.
12. Barasch E, Gottdiener JS, Marino Larsen EK, Chaves PH, Newman AB: Cardiovascular morbidity and mortality in communitydwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (the Cardiovascular Health Study). Am J Cardiol 2006; 97: 1281-1286.
13. Syuu Y, Matsubara H, Kiyooka T, Hosogi S, Mohri S, Araki J, Ohe T, Suga H: Cardiovascular beneficial effects of electroacupuncture at Neiguan (PC-6) acupoint in anesthetized open-chest dog. Jpn J Physiol 2001; 51: 231-238.
14. Lee H, Kim SY, Park J, Kim YJ, Lee H, Park HJ: Acupuncture for lowering blood pressure: Systematic review and meta-analysis. Am J Hypertens 2009; 22: 122-128.
15. Gallieni M, Olivi L, Mezzina N, Cozzolino M, Cusi D: Renal effects of combined antihypertensive treatments (in Italian). Recenti Prog Med 2010; 101: 70-77.
16. Markell MS: Potential benefits of complementary medicine modalities in patients with chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 292-299.
17. Cabyoglu MT, Ergene N, Tan U: The mechanism of acupuncture and clinical applications. Int J Neurosci 2006; 116: 115-125.
18. Steiner RP: Acupuncture Y cultural perspectives. The western view. Postgrad Med 1983; 74: 60-67.
19. Fogo AB: Mechanisms of progression of chronic kidney disease. Pediatric nephrology (Berlin, Germany) 2007; 22: 2011-2022.
20. Chen S, Ma SX: Nitric oxide in the gracile nucleus mediates depressor response to acupuncture (ST36). J Neurophysiol 2003; 90: 780-785.
21. Xu N: Effect of electroacupuncture at 'taixi' point on plasma thromboxane A2 and prostacyclin in the rabbit with renal ischemia (in Chinese). Zhen Ci Yan 1993; 18: 240-242.
22. Kuan Y, Surman J, Frystyk J, El Nahas AM, Flyvbjerg A, Haylor JL: Lack of effect of IGFI on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease. Growth Horm IGF Res 2009; 19: 219-225.
23. Clark RG: Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure. Pediatr Nephrol 2005; 20: 290-294.
24. Adamo M, Werner H, Farnsworth W, Roberts CT Jr, Raizada M, LeRoith D: Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture. Endocrinology 1988; 123: 2565-2570.
25. Chertin B, Farkas A, Puri P: Insulin-like growth factor-1 expression in reflux nephropathy. Pediatr Surg Int 2004; 20: 283-289.
26. Fernandez M, Medina A, Santos F, Carbajo E, Rodriguez J, Alvarez J, Cobo A: Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. J Am Soc Nephrol 2001; 12: 1900-1907.
27. Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G: Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921-2928.
28. Liu KD, Brakeman PR: Renal repair and recovery. Crit Care Med 2008; 36:S187-S192.
29. Schena FP: Role of growth factors in acute renal failure. Kidney Int 1998; 66:S11-S15.
30. Fukuoka H, Iida K, Nishizawa H, Imanaka M, Takeno R, Iguchi G, Takahashi M, Okimura Y, Kaji H, Chihara K, Takahashi Y: IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes. Growth Horm IGF Res 2010; 20: 212-219.
31. Handayaningsih AE, Iguchi G, Fukuoka H, Nishizawa H, Takahashi M, Yamamoto M, Herningtyas EH, Okimura Y, Kaji H, Chihara K, Seino S, Takahashi Y: Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology 2011; 152: 912-921.
32. Cao C, Kang CW, Kim SZ, Kim SH: Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy. Am J Physiol 2004; 287:H150-H156.
33. Kim DD, Pica AM, Duran RG, Duran WN: Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirculation 2006; 13: 577-585.
34. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
35. Puntel RL, Roos DH, Grotto D, Garcia SC, Nogueira CW, Rocha JB: Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: A comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci 2007; 81: 51-62.
36. Mohan S, Baylink DJ: Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and c18 SEP-PAK separation. J Clin Endocrinol Metabolism 1995; 80: 637-647.
37. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138-143.
38. Paterno JC, Freire AO, Soares MF, Franco MF, Schor N, Teixeira VP: Electroacupuncture and moxibustion attenuate the progression of renal disease in 5/6 nephrectomized rats. Kidney Blood Press Res 2008; 31: 367-373.
39. Balbi AP, Francescato HD, Marin EC, Costa RS, Coimbra TM: Roles of mitogen-activated protein kinases and angiotensin II in renal development. Braz J Med Biol Res 2009; 42: 38-43.
40. Berna MJ, Hoffmann KM, Tapia JA, Thill M, Pace A, Mantey SA, Jensen RT: CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 2007; 1773: 483-501.
41. Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK: Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 2006; 85: 1189-1199.
42. Awazu M, Omori S, Hida M: MAP kinase in renal development. Nephrol Dial Transplant 2002; 17(suppl 9):5-7.
43. Sorenson CM, Sheibani N: Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 Y/Y mice. Am J Physiol Renal Physiol 2002; 283:F1085-F1090.
44. Parameswaran N, Nambi P, Hall CS, Brooks DP, Spielman WS: Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2a activity in mesangial cells. Eur J Pharmacol 2000; 388: 133-138.
45. Schramek H, Schumacher M, Wilflingseder D, Oberleithner H, Pfaller W: Differential expression and activation of MAP kinases in dedifferentiated MDCK-focus cells. Am J Physiol 1997; 272:C383-C391.
46. Baserga R: The IGF-I receptor in cancer research. Exp Cell Res 1999; 253: 1-6.
47. Gobe G, Crane D: Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicol Lett 2010; 198: 49-55.
48. Xie Q, Nathan C: The high-output nitric oxide pathway: Role and regulation. J Leukoc Biol 1994; 56: 576-582.
49. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, Ding M: Inhibition of activator protein-1, NF - B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 2005; 280: 27888-27895.
50. Thangapazham RL, Sharma A, Maheshwari RK: Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006; 8:E443-E449.
51. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21: 361-374.
52. Oh YI, Kim JH, Kang CW: Oxidative stress in MCF-7 cells is involved in the effects of retinoic acid-induced activation of protein kinase C-delta on insulin-like growth factor-I secretion and synthesis. Growth Horm IGF Res 2010;20:101-109.
53. Kwak HJ, Song JS, No ZS, Song JH, Yang SD, Cheon HG: The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res 2005; 54: 508-513.
54. Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H: Retinoids in cancer chemoprevention. Current Cancer Drug Targets 2004; 4: 285-298.